Skip to main content
Premium Trial:

Request an Annual Quote

Floragenex Lands Investment from Seed Firm

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agricultural genomics company Floragenex has received a strategic investment from Illinois Foundation Seeds, a research and licensing company focused on corn technologies.

Floragenex did not disclose the amount of the investment, which gives Illinois Foundation Seeds access to technology for research and breeding efforts in the dent corn and sweet corn markets.

Based in Eugene and Portland Ore., Floragenex has an exclusive license to restriction site associated DNA, or RAD, sample preparation and sequencing technology that was developed at the University of Oregon.

The RAD technique supports researchers seeking SNP information in species that lack assembled reference genomes.

As part of the investment agreement, Tim Johnson, division president of Illinois Foundation Seeds, will join the board at Floragenex to “provide support as the company continues to grow into new markets and reach new customers,” the company said.

Filed under

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.